To date, there have been no reports of serious injury associated with this issue. Baxter International has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump due to the ...

Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...

Baxter told customers that its Novum IQ syringe infusion pump may fail to deliver a complete infusion and shared “reinforced guidance” to mitigate the risk. After one or more downstream occlusion ...

New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software ...

Baxter International (NYSE:BAX) has recalled its Novum IQ Syringe Pumps over concerns that they may indicate an infusion is complete when it isn’t. The pumps are used to deliver fluids, medications ...

After a drawn-out approval process, medical equipment company Baxter International received regulatory clearance for a new infusion pump machine that is expected to help the company capture more of ...

The Food and Drug Administration, stepping up its investigation into defects of medication-delivery pumps made by Baxter International Inc., has seized nearly 7,000 devices distributed from two of the ...

Baxter International Inc. Thursday settled U.S. Justice Department allegations that two of its popular medication delivery pumps were flawed and violated federal law. In a 30-page agreement approved ...

NEW YORK (MarketWatch) -- Baxter International Inc.'s Baxter Healthcare unit said Thursday the Food and Drug Administration has seized about 6,000 of its Colleague volumetric infusion pumps and about ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s ...